Clinical Trial Update: Genotype-guided Warfarin Individualized Treatment [NA]

View source ↗

Summary

A completed clinical trial evaluated genotype-guided, individualized dosing of warfarin in patients with atrial fibrillation and deep venous thrombosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Deep Venous Thrombosis

Drugs mentioned

• Warfarin (warfarin)

Snippet

Sponsor: The Third Xiangya Hospital of Central South University | Conditions: Atrial Fibrillation, Deep Venous Thrombosis | NA | Status: COMPLETED